About Contact Us Careers

Omeprazole Market Size and Forecast, by Dosage Form (Capsule, Tablet, Powder), Distribution Channel (Hospital, Retail, Online), Indication (Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux, Erosive Esophagitis) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 2477
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Omeprazole Market Outlook:

Omeprazole Market size was valued at USD 1.25 billion in 2025 and is likely to cross USD 2.35 billion by 2035, expanding at more than 6.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of omeprazole is assessed at USD 1.32 billion.

Omeprazole Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Increasing cases of chronic diseases globally are boosting market growth. As per a report generated by WHO, at the end of 2050 chronic diseases such as cancer, diabetes, and respiratory ailments will be responsible for a startling 90% of all global fatalities.

Positive results during the clinical trials of omeprazole in H. pylori elimination therapy are anticipated to increase the demand for omeprazole globally during the foreseen period. In order to treat Helicobacter pylori infection, RedHill Biopharma, for example, recently published the phase 3 findings of the Talicia capsule, which combines antibiotics and a proton pump inhibitor.

Key Omeprazole Market Insights Summary:

  • Regional Highlights:

    • By 2035, North America is projected to command a 59% revenue share in the omeprazole market because of rising ulcer prevalence and supportive cost-saving prescription services.
    • Asia Pacific is anticipated to secure a 28.6% share by 2035, stemming from increasing awareness, higher disease incidence, and active product portfolio expansion by market players.

  • Segment Insights:

    • The capsule segment in the omeprazole market is set to hold a 52% share by 2035, spurred by expanding industry growth.
    • The duodenal ulcer category is expected to maintain its leading share by 2035, underpinned by its high prevalence in key age groups and sustained clinical incidence trends.

  • Key Growth Trends:

    • Increasing Cases of Gastroesophageal Reflux
    • Increasing Awareness among People

  • Major Challenges:

    • Increasing Alternative Drugs
    • Side Effects of the Drug

  • Key Players: Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals.

Global Omeprazole Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 1.25 billion
    • 2026 Market Size: USD 1.32 billion
    • Projected Market Size: USD 2.35 billion by 2035
    • Growth Forecasts: 6.5%

  • Key Regional Dynamics:

    • Largest Region: North America (59% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, India, Japan, Germany
    • Emerging Countries: Brazil, Indonesia, South Korea, Mexico, Turkey

    • Last updated on : 19 November, 2025

Growth Drivers

  • Increasing Cases of Gastroesophageal Reflux – Omeprazole is a prescribed proton pump inhibitor (PPI) that aids in reducing acidity. Due to its effective results, this drug has been approved by regulatory agencies in order to cure heartburns as well as for the treatment of gastroesophageal reflux. Apart from the elderly population gastroesophageal reflux can affect youngsters as well which is boosting the growth of the omeprazole market. According to El-Serag et al.'s systematic review, gastroesophageal reflux prevalence in the US ranges from 18.1% to 27.8%.
  • Increasing Awareness among People- Increasing awareness among people for the treatment of gastrointestinal diseases is also expected to drive market growth. For example, the International Foundation for Functional Gastrointestinal Disorders, a not-for-profit educational and research organization, helps improve the lives of people with chronic digestive disorders. The IFFGD enhances knowledge, supports research, and improves the education of individuals.
  • Increasing prevalence of Duodenal Ulcers – An increasing number of patients who are suffering from peptic ulcers are in increased need of the treatment of the disease using the Omeprazole drug. Also, as per a report by Virtual Medical Centre, the most common disease in the world is peptic ulcer, around 10-15% of the population is affected globally. Men and the elderly population generally suffer from peptic ulcers. This factor is bolstering the market growth rapidly.

Challenges

  • Increasing Alternative Drugs – Pantoprazole, lansoprazole, and esomeprazole are some of the alternative drugs of Omeprazole which are used widely around the world. Due to these alternatives in the market, the growth of the omeprazole market is expected to be hampered.
  • Side Effects of the Drug
  • Higher Cost of the Drug

Omeprazole Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

6.5%

Base Year Market Size (2025)

USD 1.25 billion

Forecast Year Market Size (2035)

USD 2.35 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Omeprazole Market Segmentation:

Dosage Form Segment Analysis

The capsule segment is expected to occupy 52% of the largest market share by 2035. The tablets are easy to handle and inexpensive. Also, 2020 will see a 24% increase in total medication use to 4.5 trillion doses. More than half of the world's population will take more than one dose of medication per person per day, up from one-third in 2005, with India, China, Brazil, and Indonesia leading the way. This may result in the expansion of industry growth.

Indication Segment Analysis

The duodenal ulcer category is expected to drive market growth. This category was leading the market in 2019 as well. Duodenal ulcers are most commonly observed in the age groups of 25-55 years. With age, the incidence of peptic ulcer increased to a peak of 28.8% in the 5th decade of life. Duodenal ulcers are thought to affect 5 to 15% of people in the West, according to numerous studies that have assessed their prevalence. These factors are driving the growth of this segment. 

Our in-depth analysis of the global market includes the following segments:

     Dosage Form
  • Capsule
  • Tablet
  • Powder

     Distribution Channel
  • Hospital
  • Retail
  • Online

     Indication

  • Duodenal Ulcer
  • Gastric Ulcer
  • Gastroesophageal Reflux
  • Erosive Esophagitis
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Omeprazole Market - Regional Analysis

North American Market Insights

North America industry is set to dominate majority revenue share of 59% by 2035. In 2020 the region experienced the prevalence of H. pylori infection which causes ulcers. Additionally, peptic ulcers are prominent in the US, around 4.5 million individuals are affected yearly. Also, about 10% of the US population is affected by duodenal ulcers. For example, there is an online service that helps people save around 80% on their prescription costs by working with large pharmacies in the US. These key factors are bolstering the market growth of Omeprazole in the region.

APAC Market Insights

Asia Pacific to hold a share of 28.6% by 2035. Market growth in the region is driven by greater awareness amongst target audiences about treating this condition, growing incidences, and intensified focus of key market players to increase their product portfolio. Vonoprazan, a product that is FDA-cleared for the treatment of gastroesophageal reflux disease by Phantom Pharmaceutics, was made available to Japanese consumers and another Asian country in March 2022. In addition, with the increased demand for gastroesophageal disease treatment in the Asia region, a number of players have been expanding their presence there.

Omeprazole Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Omeprazole Market Players:

    • Boehringer Ingelheim
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AstraZeneca Plc.
    • Azurity Pharma
    • Perrigo Company Plc.
    • Salix pharmaceuticals

Recent Developments

  • Perrigo Company, a leading supplier of consumer health products announces today that the US Food and Drug Administration has given final clearance for omeprazole magnesium delayed mini capsules, 20mg OTC. Perrigo is planning to make Omeprazole Minis available in the latter part of this year.
  • AstraZeneca announced to sell omeprazole and its associated brand's global commercial rights to Cheplapharm Arzneimittel GmbH.
  • Report ID: 2477
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of omeprazole is assessed at USD 1.32 billion.

The global omeprazole market size was around USD 1.25 billion in 2025 and is likely to expand at a CAGR of more than 6.5%, surpassing USD 2.35 billion revenue by 2035.

By 2035, North America is projected to command a 59% revenue share in the omeprazole market because of rising ulcer prevalence and supportive cost-saving prescription services.

Key players in the market include Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals.

Omeprazole Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos